Sanction Bid in Dismissed IP Case Still Valid, Sloan Says

By Andrew Strickler · January 20, 2017, 3:57 PM EST

A lawyer representing the Sloan Kettering Institute on Friday urged a New York federal judge to keep alive a sanction bid against counsel for a gene therapy company that sued the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Letter

Case Information

Case Title

Errant Gene Therapeutics, LLC et al v. Sloan-Kettering Institute for Cancer Research

Case Number

Court

New York Southern

Nature of Suit

Patent

Date Filed

March 18, 2015

Recent Articles By Andrew

March 20, 2024
4th Circ. Backs Rockefeller Group in Guatemalans' Syphilis Suit
July 19, 2023
Crowell Urges Delay In Walgreens-Humana Conflict Ruling
April 28, 2023
Nonprofit Attys, Dinsmore Seek Swift End To LabMD Suit
February 13, 2023
LabMD Sues Nonprofit, Dinsmore Over FTC Enforcement Case
October 12, 2022
Panama Foundation, Fla. Firm Settle Suit Over $4M Investment
September 30, 2022
Locke Lord Is Stuck With Failed Health Plan Malpractice Suit
July 01, 2022
The Chattiest Justice Of The Term Is ...
May 03, 2022
Leak Casts Pall On High Court Ahead Of Final Abortion Ruling
August 30, 2021
Meet The Lawyers On Deck At The Elizabeth Holmes Trial
July 06, 2021
The Sharpest Dissents From The Supreme Court Term